scholarly journals A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)

Diabetes Care ◽  
2020 ◽  
Vol 43 (8) ◽  
pp. 1710-1716 ◽  
Author(s):  
Wendy S. Lane ◽  
Elena Favaro ◽  
Naveen Rathor ◽  
Hak C. Jang ◽  
Maiken I.S. Kjærsgaard ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Trial ◽  
Insulin Aspart ◽  
Insulin Degludec ◽  
Efficacy And Safety ◽  
Diabetes Onset ◽  
Acting Insulin ◽  
Fast Acting

1034-P: Efficacy and Safety of Fast-Acting Insulin Aspart According to Baseline HbA1c in Adults with Type 2 Diabetes Treated with a Basal-Bolus Regimen

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1034-P
Author(s):  
EDWARD FRANEK ◽  
MAGNUS EKELUND ◽  
ÓLÖF THÓRISDÓTTIR ◽  
HAK CHUL JANG ◽  
KATARINA LALIC ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Aspart ◽  
Efficacy And Safety ◽  
Baseline Hba1c ◽  
Acting Insulin ◽  
Basal Bolus ◽  
Fast Acting

scholarly journals Fast‐acting insulin aspart in people with type 2 diabetes: Earlier onset and greater initial exposure and glucose‐lowering effect compared with insulin aspart

2019 ◽  
Vol 21 (9) ◽  
pp. 2068-2075 ◽  
Author(s):  
Thomas R. Pieber ◽  
Eva Svehlikova ◽  
Martina Brunner ◽  
Inge B. Halberg ◽  
Karen Margrete Due Thomsen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Aspart ◽  
Initial Exposure ◽  
Glucose Lowering ◽  
Lowering Effect ◽  
Acting Insulin ◽  
Glucose Lowering Effect ◽  
Fast Acting
Sign in / Sign up

Export Citation Format

Share Document